Keitaro Fukuda

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Ulcerative Colitis

Basal Cell Carcinoma

Immune Response

Top Venues

The Journal of experimental medicine

Experimental dermatology

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Takeru Funakoshi, Yoshio Nakamura, Ikuko Hirai, Kenta Kobayashi, Keitaro Fukuda, Taku Iwata
Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis. Experimental dermatology 33 (2) (2024)
Keitaro Fukuda
Impact of EGFR and MEK inhibition on hair follicles: partial hair follicle immune privilege collapse and excessive IL-33 secretion. The British journal of dermatology (2024)
Takeru Funakoshi, Yoshio Nakamura, Ikuko Hirai, Kenta Kobayashi, Keitaro Fukuda, Taku Iwata
Proposal for the optimal staging of extramammary Paget's disease: A retrospective analysis of 57 cases with distant metastasis. Experimental dermatology 33 (2) (2024)
Keitaro Fukuda
Immune Regulation by Cytosolic DNA Sensors in the Tumor Microenvironment. Cancers 15 (7) (2023)
Keitaro Fukuda
IFNγ score-based neoadjuvant immunotherapy for stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Keitaro Fukuda
IFNγ score-based neoadjuvant immunotherapy for stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Keitaro Fukuda
IFNγ score-based neoadjuvant immunotherapy for stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Keitaro Fukuda
IFNγ score-based neoadjuvant immunotherapy for stage III melanoma. The Journal of experimental medicine 220 (5) (2023)
Takaiyuki Fusumae, Keitaro Fukuda, Ikuko Hirai, Yoshio Nakamura, Kenta Kobayashi, Keiji Tanese, Kazuhiro Matsumoto, Takashi Iwata, Takeru Funakoshi
Management and outcomes of hydronephrosis in patients with metastatic extramammary Paget's disease: A retrospective analysis. The Journal of dermatology 49 (8) (2022)
Yoshio Nakamura, Keiji Tanese, Kaori Kameyama, Yu Ota, Takaiyuki Fusumae, Ikuko Hirai, Keitaro Fukuda, Takeru Funakoshi
Cutaneous eyelid melanoma with lacrimal sac metastasis: the potential role of lacrimal fluid as a metastatic pathway. Clinical and experimental dermatology 47 (12) (2022)
Sakiko Takeuchi, Keitaro Fukuda, Ryo Tanaka, Takeru Funakoshi, Hayato Takahashi, Masayuki Amagai, Akiko Tanikawa
Successful management of tumor necrosis factor-α inhibitor-induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis. The Journal of dermatology (2022)
Keitaro Fukuda, Ken Okamura, Rebecca L Riding, Xueli Fan, Khashayar Afshari, Nazgol-Sadat Haddadi, Sean Matthew McCauley, Mehmet Hakan Guney, Jeremy Luban, Takeru Funakoshi, Tomonori Yaguchi, Yutaka Kawakami, Anastasia Khvorova, Katherine A Fitzgerald, John E Harris
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of experimental medicine 218 (9) (2021)
Rebecca L Riding, Jillian M Richmond, Keitaro Fukuda, John E Harris
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy. Pigment cell & melanoma research 34 (4) (2020)